<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The Case For A Follow-On Biologics Global Health Exclusivity Incentive</title>
	<atom:link href="http://healthaffairs.org/blog/2009/07/14/the-case-for-a-follow-on-biologics-global-health-exclusivity-incentive/feed/" rel="self" type="application/rss+xml" />
	<link>http://healthaffairs.org/blog/2009/07/14/the-case-for-a-follow-on-biologics-global-health-exclusivity-incentive/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-case-for-a-follow-on-biologics-global-health-exclusivity-incentive</link>
	<description>The Policy Journal of the Health Sphere</description>
	<lastBuildDate>Thu, 24 May 2012 07:58:29 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>By: The Case For A Follow-on Biologics Global Health Exclusivity Incentive &#124; Bioinformatics World Wide</title>
		<link>http://healthaffairs.org/blog/2009/07/14/the-case-for-a-follow-on-biologics-global-health-exclusivity-incentive/comment-page-1/#comment-28631</link>
		<dc:creator>The Case For A Follow-on Biologics Global Health Exclusivity Incentive &#124; Bioinformatics World Wide</dc:creator>
		<pubDate>Wed, 15 Jul 2009 16:56:11 +0000</pubDate>
		<guid isPermaLink="false">http://healthaffairs.org/blog/?p=1572#comment-28631</guid>
		<description>[...] the original here: The Case For A Follow-on Biologics Global Health Exclusivity Incentive               Tagged with: [...]</description>
		<content:encoded><![CDATA[<p>[...] the original here: The Case For A Follow-on Biologics Global Health Exclusivity Incentive               Tagged with: [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

